Severe acute hepatitis after thymoglobulin induction before islet transplantation

Therapie. 2018 Dec;73(6):545-546. doi: 10.1016/j.therap.2018.04.004. Epub 2018 May 3.

Authors

Quentin Perrier¹, Rachel Tetaz², Magalie Baudrant³, Marion Lepelley⁴, Thierry Berney⁵, Pierre-Yves Benhamou⁶, Sandrine Lablanche⁶; STABILOT study group

Affiliations

¹ Department of clinical pharmacy, Grenoble Alpes university hospital, 38043 Grenoble, France. Electronic address: [email protected].
² Department of nephrology, pole DigiDune, Grenoble Alpes university hospital, 38043 Grenoble, France.
³ Department of clinical pharmacy, Grenoble Alpes university hospital, 38043 Grenoble, France.
⁴ Department of pharmacovigilance, Grenoble Alpes university hospital, 38043 Grenoble, France.
⁵ Department of surgery, islet isolation and transplantation center, university of Geneva hospitals, 1211 Geneva, Switzerland.
⁶ Department of endocrinology, pole DigiDune, Grenoble Alpes university hospital, 38043 Grenoble, France.

PMID: 29786507
DOI: 10.1016/j.therap.2018.04.004

No abstract available

Keywords: Hepatitis side effect; Islet transplantation; Thymoglobulin.

Publication types

Case Reports
Letter

MeSH terms

Acute Disease
Antilymphocyte Serum / adverse effects*
Chemical and Drug Induced Liver Injury / diagnosis*
Chemical and Drug Induced Liver Injury / etiology
Diabetes Mellitus, Type 1 / immunology
Diabetes Mellitus, Type 1 / therapy
Female
Graft Rejection / immunology
Graft Rejection / prevention & control
Hepatitis / diagnosis*
Hepatitis / etiology
Hepatitis / immunology
Humans
Immunosuppressive Agents / adverse effects*
Islets of Langerhans Transplantation* / adverse effects
Islets of Langerhans Transplantation* / immunology
Middle Aged
Severity of Illness Index
Transplantation Conditioning / adverse effects*
Transplantation Conditioning / methods

Substances

Antilymphocyte Serum
Immunosuppressive Agents
thymoglobulin